Φορτώνει......
Elevated methylation of cyclin dependent kinase inhibitor 2B contributes to the risk of coronary heart disease in women
Cyclin dependent kinase inhibitor 2B (CDKN2B) encodes a cyclin-dependent kinase inhibitor that may enhance the formation of atherosclerotic plaques. The aim of the present study was to investigate the contribution of CDKN2B promoter methylation on the risk of coronary heart disease (CHD). The presen...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Exp Ther Med |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
D.A. Spandidos
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6307461/ https://ncbi.nlm.nih.gov/pubmed/30651784 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2018.6920 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|